Search Results 61-70 of 38430 for breast cancer
This is a two arm Phase III trial in first and second-line HER2 negative patients with locally recurrent or metastatic breast cancer. The primary endpoint is ...
Mayo Clinic breast cancer specialists provide compassionate, comprehensive care for people with breast cancer during and after treatment.
Immunohistochemistry for HER2 shows positive membrane staining in this infiltrating ductal carcinoma. At the molecular level, breast cancer is typically broken ...
... breast cancer, which is one of the most aggressive and lethal types of breast cancer. In this study, Mayo investigators identified that the drug 5-aza-2 ...
Another very rare type of cancer called breast implant-associated squamous cell carcinoma (BIA-SCC) also has been linked to breast implants. Like BIA-ALCL, it ...
Learn about this rare, aggressive type of breast cancer that causes a swollen breast. Treatments include surgery, radiation, chemotherapy and others.
Triple-negative breast cancer is known for its resistance to targeted therapies, leaving chemotherapy as the primary treatment option. While most patients ...
Research from Mayo Clinic finds breast-conserving surgery yields a low five-year recurrence rate for women with multiple ipsilateral breast cancer.
Researchers found most women who survive breast cancer beyond 10 years are at risk to develop serious medical conditions including heart disease, ...
Soy contains isoflavones, which are plant estrogens and different from human estrogens, which can increase the risk of breast cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.